Vizionfocus Inc. (TPE:4771)
Taiwan · Delayed Price · Currency is TWD 174.00
-1.00 (-0.57%)
Feb 2, 2026, 1:35 PM CST
Vizionfocus Revenue
Vizionfocus had revenue of 853.60M TWD in the quarter ending September 30, 2025, with 14.97% growth. This brings the company's revenue in the last twelve months to 3.30B, up 8.25% year-over-year. In the year 2024, Vizionfocus had annual revenue of 3.00B with 16.71% growth.
Revenue (ttm)
3.30B
Revenue Growth
+8.25%
P/S Ratio
3.11
Revenue / Employee
n/a
Employees
438
Market Cap
10.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00B | 429.81M | 16.71% |
| Dec 31, 2023 | 2.57B | 737.88M | 40.23% |
| Dec 31, 2022 | 1.83B | 414.63M | 29.21% |
| Dec 31, 2021 | 1.42B | 564.54M | 66.02% |
| Dec 31, 2020 | 855.15M | 270.28M | 46.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pegavision | 6.90B |
| St.Shine Optical | 4.40B |
| Visco Vision | 4.07B |
| Formosa Optical Technology | 3.98B |
| Pacific Hospital Supply | 2.47B |
| Nang Kuang Pharmaceutical | 2.22B |
| Bioteque | 2.07B |
| ICARES Medicus | 1.09B |